Jochen Graff
Pharmazentrum Frankfurt/ZAFES
Institute of Clinical Pharmacology
University Hospital
Frankfurt/Main
Germany
Name/email consistency: high
- Effects of the oral, direct factor xa inhibitor rivaroxaban on platelet-induced thrombin generation and prothrombinase activity. Graff, J., von Hentig, N., Misselwitz, F., Kubitza, D., Becka, M., Breddin, H.K., Harder, S. J. Clin. Pharmacol (2007)
- Effects of parecoxib and dipyrone on platelet aggregation in patients undergoing meniscectomy: a double-blind, randomized, parallel-group study. Graff, J., Arabmotlagh, M., Cheung, R., Geisslinger, G., Harder, S. Clin. Ther (2007)
- Investigation of the PADA as a method for monitoring GPIIb/IIIa inhibitors and other antiplatelet agents. Graff, J., Harder, S. Semin. Thromb. Hemost. (2005)
- Anti-inflammatory effects of clopidogrel intake in renal transplant patients: effects on platelet-leukocyte interactions, platelet CD40 ligand expression, and proinflammatory biomarkers. Graff, J., Harder, S., Wahl, O., Scheuermann, E.H., Gossmann, J. Clin. Pharmacol. Ther. (2005)
- Pharmacodynamic profile of antiplatelet agents: marked differences between single versus costimulation with platelet activators. Graff, J., Klinkhardt, U., Harder, S. Thromb. Res. (2004)
- Pharmacodynamic characterization of the interaction between the glycoprotein IIb/IIIa inhibitor YM337 and unfractionated heparin and aspirin in humans. Graff, J., Klinkhardt, U., Westrup, D., Kirchmaier, C.M., Breddin, H.K., Harder, S. Br. J. Clin. Pharmacol (2003)
- Immunosuppressive therapy regimen and platelet activation in renal transplant patients. Graff, J., Klinkhardt, U., Harder, S., Wegert, W., Lenz, T., Scheuermann, E.H., Gossmann, J. Clin. Pharmacol. Ther. (2002)
- Platelet CD62 expression and PDGFAB secretion in patients undergoing PTCA and treatment with abciximab. Graff, J., Andries, D., Elsner, M., Westrup, D., Bassus, S., Franz, N., Klinkhardt, U., Harder, S. Br. J. Clin. Pharmacol (2001)